AstraZeneca Resumes UK Trials Of COVID-19 Vaccine

by 48N-Developer



AstraZeneca said that it has resumed British clinical trials of its COVID-19 vaccine, one of the most advanced in development, after getting the green light from safety watchdogs. The late-stage trials were suspended this week after an illness in a study subject.







Leave a Comment